Vaxart, Inc.

COVID is not going away. A Los Angeles Times article highlights a recent surge of #COVID19 cases in California. To address public health threats, Vaxart continues its work to develop a next generation oral pill COVID-19 vaccine. https://lnkd.in/eGr9xyie #PillThatMovesTheNeedle

From Nature Magazine: Bird flu could become a human pandemic. How are countries preparing? https://lnkd.in/e_bvx4p5 Vaxart believes mucosal immunity is critical, as it may provide protection against pathogens that enter at a mucosal surface. #PillThatMovesTheNeedle #Vaxart #publichealth

Axios reports that COVID-19 cases are growing or likely growing in 45 states and territories. https://bit.ly/3Y7eYJd Vaxart believes its investigational oral pill vaccine platform can better meet societal needs for many infectious disease pandemic and endemic threats. #PillThatMovesTheNeedle #Vaxart #COVID19 #pandemicpreparedness

From Axios: Global battle to reach millions of children missing out on vaccination. https://bit.ly/464a01Z Vaxart’s oral norovirus vaccine candidate is in clinical trials to test if it could help nursing mothers vaccinate and protect this vulnerable population. #PillThatMovesTheNeedle #Vaxart #norovirus

From Tina Reed and Adriel Bettelheim of Axios: Kids' vaccination stalls globally, WHO finds, leaving 2.7 million more kids lacking protection they need. https://bit.ly/464a01Z Vaxart polling has shown a pill option may help us vaccinate more people. #PillThatMovesTheNeedle #Vaxart #vaccines

BARDA on working with Vaxart: “We look at every investment we make as a true partnership, where we’re working with the company to help give them the best chance of success to move those products forward.” https://bit.ly/3zioZsC #PillThatMovesTheNeedle #Vaxart #BARDA #COVID19

Vaxart Chief Scientific Officer Dr. Sean Tucker on testing for asymptomatic infection: “It’s an incredible expense, and we’re grateful.” The testing investment reflects BARDA’s aspirations for Project NextGen-funded trials. https://bit.ly/3zioZsC #PillThatMovesTheNeedle #Vaxart #COVID19 #BARDA

Vaxart Chief Executive Officer Steven Lo compared working with BARDA on its recently announced Project NextGen award to “collaborating with a large pharmaceutical company, bouncing ideas off each other,” in this Endpoints article. https://bit.ly/3zioZsC #PillThatMovesTheNeedle #Vaxart #COVID19 #BARDA

Happy Independence Day! Vaxart proudly commemorates July 4th, celebrating the birth of America and the values of freedom, unity, and perseverance that define us. #July4 #IndependenceDay #Freedom #Vaxart #PillThatMovesTheNeedle

Vaxart is highlighted in an Endpoints News article by Max Bayer on a Biomedical Advanced Research and Development Authority (BARDA) multibillion-dollar effort to fund biotechs for COVID-19. The article notes that BARDA sees Vaxart as a key part of Project NextGen. https://bit.ly/3zioZsC #PillThatMovesTheNeedle #COVID19